{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:47:26Z","timestamp":1790214446008,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009665","name":"Vehicle Racing Commemorative Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00392-019-01591-y","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T18:02:31Z","timestamp":1577124151000},"page":"988-998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging"],"prefix":"10.1007","volume":"109","author":[{"given":"Yoshinori","family":"Kagioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Okune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kobuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1391-2864","authenticated-orcid":false,"given":"Yoshitaka","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"1591_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/hrt.2005.080481","volume":"92","author":"AR Doughan","year":"2006","unstructured":"Doughan AR, Williams BR (2006) Cardiac sarcoidosis. Heart 92:282\u2013288","journal-title":"Heart"},{"key":"1591_CR2","first-page":"50","volume":"6","author":"E Hulten","year":"2016","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R (2016) Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther 6:50\u201363","journal-title":"Cardiovasc Diagn Ther"},{"key":"1591_CR3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","volume":"10","author":"V Kouranos","year":"2017","unstructured":"Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E (2017) Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging 10:1437\u20131447","journal-title":"JACC Cardiovasc Imaging"},{"key":"1591_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","volume":"10","author":"GC Coleman","year":"2017","unstructured":"Coleman GC, Shaw PW, Balfour PC Jr, Gonzalez JA, Kramer CM, Patel AR, Salerno M (2017) Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis. JACC Cardiovasc Imaging 10:411\u2013420","journal-title":"JACC Cardiovasc Imaging"},{"key":"1591_CR5","doi-asserted-by":"publisher","first-page":"e000437","DOI":"10.1136\/openhrt-2016-000437","volume":"3","author":"M Yasuda","year":"2016","unstructured":"Yasuda M, Iwanaga Y, Kato T, Izumi T, Inuzuka Y, Nakamura T, Miyaji Y, Kawamura T, Ikeguchi S, Inoko M, Kurita T, Miyazaki S (2016) Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis. Open Heart 3:e000437","journal-title":"Open Heart"},{"key":"1591_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/eurjhf\/hfq161","volume":"13","author":"CV Bourantas","year":"2011","unstructured":"Bourantas CV, Loh HP, Bragadeesh T, Rigby AS, Lukaschuk EI, Garg S, Tweddel AC, Alamgir FM, Nikitin NP, Clark AL, Cleland JG (2011) Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. Eur J Heart Fail 13:52\u201360","journal-title":"Eur J Heart Fail"},{"key":"1591_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.113.002518","volume":"128","author":"A Gulati","year":"2013","unstructured":"Gulati A, Ismail TF, Jabbour A, Alpendurada F, Guha K, Ismail NA, Raza S, Khwaja J, Brown TD, Morarji K, Liodakis E, Roughton M, Wage R, Pakrashi TC, Sharma R, Carpenter JP, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK (2013) The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 128:1623\u20131633","journal-title":"Circulation"},{"key":"1591_CR8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00392-017-1117-y","volume":"106","author":"J Peyrou","year":"2017","unstructured":"Peyrou J, Chauvel C, Pathak A, Simon M, Dehant P, Abergel E (2017) Preoperative right ventricular dysfunction is a strong predictor of 3 years survival after cardiac surgery. Clin Res Cardiol 106:734\u2013742","journal-title":"Clin Res Cardiol"},{"key":"1591_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","volume":"7","author":"B Philips","year":"2014","unstructured":"Philips B, Madhavan S, James CA, te Riele AS, Murray B, Tichnell C, Bhonsale A, Nazarian S, Judge DP, Calkins H, Tandri H, Cheng A (2014) Arrhythmogenic right ventricular dysplasia\/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol 7:230\u2013236","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1591_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17996\/anc.17-00042","volume":"31","author":"F Terasaki","year":"2017","unstructured":"Terasaki F, Yoshinaga K (2017) New Guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol 31:42\u201345","journal-title":"Ann Nucl Cardiol"},{"key":"1591_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.amjcard.2015.01.562","volume":"115","author":"Y Takaya","year":"2015","unstructured":"Takaya Y, Kusano KF, Nakamura K, Ito H (2015) Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis. Am J Cardiol 115:1293\u20131297","journal-title":"Am J Cardiol"},{"key":"1591_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","volume":"45","author":"JP Smedema","year":"2005","unstructured":"Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683\u20131690","journal-title":"J Am Coll Cardiol"},{"key":"1591_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2214\/ajr.185.1.01850110","volume":"185","author":"E Tadamura","year":"2005","unstructured":"Tadamura E, Yamamuro M, Kubo S, Kanao S, Saga T, Harada M, Ohba M, Hosokawa R, Kimura T, Kita T, Togashi K (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185:110\u2013115","journal-title":"AJR Am J Roentgenol"},{"key":"1591_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685\u2013713","journal-title":"J Am Soc Echocardiogr"},{"key":"1591_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/eurheartj\/ehr490","volume":"33","author":"ER Buechel","year":"2012","unstructured":"Buechel ER, Mertens LL (2012) Imaging the right heart: the use of integrated multimodality imaging. Eur Heart J 33:949\u2013960","journal-title":"Eur Heart J"},{"key":"1591_CR16","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","volume":"9","author":"E Hulten","year":"2016","unstructured":"Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, Bittencourt MS, Murthy VL, Kwong R, Di Carli MF, Blankstein R (2016) Presence of Late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis. Circ Cardiovasc Imaging 9:e005001","journal-title":"Circ Cardiovasc Imaging"},{"key":"1591_CR17","doi-asserted-by":"publisher","first-page":"e003738","DOI":"10.1161\/CIRCIMAGING.115.003738","volume":"9","author":"G Murtagh","year":"2016","unstructured":"Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, Yu Z, Addetia K, Mor-Avi V, Moss JD, Hogarth DK, Sweiss NJ, Lang RM, Patel AR (2016) Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging 9:e003738","journal-title":"Circ Cardiovasc Imaging"},{"key":"1591_CR18","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","volume":"7","author":"T Crawford","year":"2014","unstructured":"Crawford T, Mueller G, Sarsam S, Prasitdumrong H, Chaiyen N, Gu X, Schuller J, Kron J, Nour KA, Cheng A, Ji SY, Feinstein S, Gupta S, Ilg K, Sinno M, Abu-Hashish S, Al-Mallah M, Sauer WH, Ellenbogen K, Morady F, Bogun F (2014) Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol 7:1109\u20131115","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1591_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ehf2.12201","volume":"5","author":"JP Smedema","year":"2018","unstructured":"Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns HJGM (2018) Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. ESC Heart Fail 5:157\u2013171","journal-title":"ESC Heart Fail"},{"key":"1591_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","volume":"104","author":"F Tavora","year":"2009","unstructured":"Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A (2009) Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104:571\u2013577","journal-title":"Am J Cardiol"},{"key":"1591_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","volume":"8","author":"S Kumar","year":"2015","unstructured":"Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, Michaud GF, Tedrow UB, Stevenson WG (2015) Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 8:87\u201393","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1591_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","volume":"23","author":"JL Schuller","year":"2012","unstructured":"Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, Nguyen DT, Aleong RG, Varosy PD, Weinberger HD, Sauer WH (2012) Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 23:925\u2013929","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1591_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","volume":"63","author":"R Blankstein","year":"2014","unstructured":"Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF (2014) Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 63:329\u2013336","journal-title":"J Am Coll Cardiol"},{"key":"1591_CR24","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","volume":"69","author":"M Guazzi","year":"2017","unstructured":"Guazzi M, Naeije R (2017) Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol 69:1718\u20131734","journal-title":"J Am Coll Cardiol"},{"key":"1591_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.amjcard.2012.09.031","volume":"111","author":"D Dobarro","year":"2013","unstructured":"Dobarro D, Schreiber BE, Handler C, Beynon H, Denton CP, Coghlan JG (2013) Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data. Am J Cardiol 111:278\u2013285","journal-title":"Am J Cardiol"},{"key":"1591_CR26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1378\/chest.09-2002","volume":"138","author":"RP Baughman","year":"2010","unstructured":"Baughman RP, Engel PJ, Taylor L, Lower EE (2010) Survival in sarcoidosis associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 138:1078\u20131085","journal-title":"Chest"},{"key":"1591_CR27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00392-018-1265-8","volume":"107","author":"MV Polito","year":"2018","unstructured":"Polito MV, Stoebe S, Leifels L, Stumpp P, Solty K, Galasso G, Piscione F, Laufs U, Klingel K, Hagendorff A (2018) Cardiac sarcoidosis: a challenging diagnosis. Clin Res Cardiol 107:980\u2013986","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-019-01591-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T07:54:23Z","timestamp":1665302063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-019-01591-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s00392-019-01591-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"assertion":[{"value":"25 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments and was approved by Kindai University Faculty of Medicine Ethics Committee in Osakasayama, Japan, and all subjects provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}